Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases and Pregnancy Complications

Explore clinical trials studying Female Urogenital Diseases and Pregnancy Complications. Study availability and eligibility vary by location and protocol.

26,814 public trials 4,526 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases and Pregnancy Complications trial results

Terminated

A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors

NCT05572684

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Cervical Cancer, +52 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • St. Elizabeth Edgewood Hospital Edgewood, Kentucky, United States
  • Ochsner Cancer Institute New Orleans, Louisiana, United States
View all 17 locations
View Trial Details
Terminated

Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery

NCT05401058

Conditions
Confusion, Delirium, Digestive System Disease, +20 more
Locations
  • The first Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Henan Provincial People Hospital Zhengzhou, Henan, China
  • Renji Hospital, Shanghai Jiaotong University School of Medicine Pudong, Shanghai Municipality, China
  • Second hospital of Shanxi Medical University Taiyuan, Shanxi, China
View Trial Details
Terminated

A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

NCT05226507

Conditions
ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
Locations
  • Honor Health Phoenix, Arizona, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Yale Gynecologic Oncology New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Terminated

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

NCT00799110

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Terminated

Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporesponsive Hemodialysis-dependent Chronic Kidney Disease Subjects With Anemia

NCT02075463

Conditions
Anaemia, Anemia, Chronic Disease, +13 more
Locations
  • GSK Investigational Site Azusa, California, United States
  • GSK Investigational Site Glendale, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Simi Valley, California, United States
View Trial Details
Terminated

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

NCT03869190

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • UCLA Department of Medicine Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Kentucky Chandler Medical Center Lexington, Kentucky, United States
View all 33 locations
View Trial Details

Related conditions